Archives of Pharmacal Research

, Volume 16, Issue 3, pp 254–256 | Cite as

Recognition of pharmacophore of ar-turmerone for its anticancer activity

  • Kyong-Up Baik
  • Sang-Hun Jung
  • Byung-Zun Ahn


For the evaluation of the role of α,β-unsaturated ketone portion of ar-turmerone for its activity, the structural variation of this structural unit was performed to omit its alkylating property. Thus compounds2, 3, and4 were prepared and their cytotoxicities were determined against three different leukemia cell lines (HL-60, K-562, and L1210)in vitro. The biological inactivity against three different cell lines of these analogues implies that the α,β-unsaturated ketone of ar-turmerone is the essential pharmacophore for its activity.

Key words

Pharmacophore ar-Turmerone Cytotoxicity Anticancer activity 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References Cited

  1. Ahn, B. Z. and Lee, J. H., Cytotoxic and cytotoxicity-potentiating effects of the curcuma root on L1210 cell.Korean J. Pharmacognosy, 20, 223–226 (1989).Google Scholar
  2. Breitner, E., Rogniski, E., Rylander, P. N., Low pressure hydrogenation of ketone with platinum metal catalysts.J. Org. Chem., 24, 1855–1857 (1959).CrossRefGoogle Scholar
  3. Greenwald R., Chaykovsky, M., Corey, E. J., The Wittig reaction using methylsulfenyl carbaion-dimethylsulf-oxide.J. Org. Chem., 28, 1128–1129 (1963).CrossRefGoogle Scholar
  4. Honwad, V. K. and Rao, A. S., Absolute configuration of ar-turmerone.Tetrahedron, 20, 2921–2925 (1964).CrossRefGoogle Scholar
  5. Itokawa, H., Hirayamo, F., Funakoshi, K., and Takeya, K., Studies on the antitumor bisabolane sesquiterpenoids isolated from Curcuma xanthorriza.Chem. Pharm. Bull., 33, 3488–3492 (1985).PubMedGoogle Scholar
  6. Kraus, G. A., Frazier, K., Selective reduction via enolate protection.J. Org. Chem., 45, 4262–4263 (1980).CrossRefGoogle Scholar
  7. Lee, J. H., Kang, S. K., and Ahn, B. Z., Antineoplastic natural products and the analogues(XI)-Cytotoxic activity against L1210 cell of some raw drugs from the oriental medicine and falklore.Korean J. Pharmacognosy, 17, 286–291 (1986).Google Scholar
  8. Matthes, H. W. D., Luu, B., and Ourisson, G., Cytotoxic components ofZingiber zerumbet, Curcuma zedoaria, andCurcuma domestica.Phytochemistry, 19, 2643–2650 (1980).CrossRefGoogle Scholar
  9. Oh, W. G., Baik, K. U., Jung, S. H. Ahn, B. Z., The role of substituents of ar-turmerone for its anticancer activity.Arch. Pharm. Res., 15, 256–262 (1992).CrossRefGoogle Scholar
  10. Perrin, D. D. and Armarego, W. L. F.,Purification of Laboratory Chemicals, 3rd Edition, Pergamon, Oxford, 1988, pp. 65–309.Google Scholar
  11. Rupe, V. K. and Wiederkehr, F., Zur kennites des arturmerone aus dem cucuma-ol.Helv. Chim. Acta, 7, 654–656 (1924).CrossRefGoogle Scholar
  12. Thayer, P. S., Himmerlfarb, P. and Watts, G. L., Cytotoxicity assay with L1210 cellin vitro, Comparison with L1210 in vitro and KB cellsin vitro.Cancer Chem. Rep., 2, 1–25 (1971).Google Scholar

Copyright information

© The Pharmaceutical Society of Korea 1993

Authors and Affiliations

  • Kyong-Up Baik
    • 1
  • Sang-Hun Jung
    • 1
  • Byung-Zun Ahn
    • 1
  1. 1.College of PharmacyChung-Nam National UniversityTaejonKorea

Personalised recommendations